Hutchmed Drc Stock Price on November 12, 2024

HCM Stock  USD 17.41  0.05  0.29%   
Below is the normalized historical share price chart for HUTCHMED DRC extending back to March 17, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of HUTCHMED DRC stands at 17.41, as last reported on the 26th of November, with the highest price reaching 17.71 and the lowest price hitting 17.29 during the day.
IPO Date
17th of March 2016
200 Day MA
17.9852
50 Day MA
18.759
Beta
0.746
 
Yuan Drop
 
Covid
If you're considering investing in HUTCHMED Stock, it is important to understand the factors that can impact its price. As of now, HUTCHMED Stock is not too volatile. HUTCHMED DRC holds Efficiency (Sharpe) Ratio of 0.0187, which attests that the entity had a 0.0187% return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for HUTCHMED DRC, which you can use to evaluate the volatility of the firm. Please check out HUTCHMED DRC's market risk adjusted performance of (0.01), and Risk Adjusted Performance of 0.0081 to validate if the risk estimate we provide is consistent with the expected return of 0.0593%.
  
HUTCHMED Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0187

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskHCMHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.17
  actual daily
28
72% of assets are more volatile

Expected Return

 0.06
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average HUTCHMED DRC is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HUTCHMED DRC by adding it to a well-diversified portfolio.
Price Book
4.0094
Enterprise Value Ebitda
36.807
Price Sales
4.975
Shares Float
515.9 M
Wall Street Target Price
28.5308

Related Headline

Moleculin Biotech Headline on 12th of November 2024

Operator Greetings, and welcome to the Moleculin Biotech Quarterly Update Conference Call and Webcast. At this time, all participants are in listen only mode.

HUTCHMED DRC Valuation on November 12, 2024

It is possible to determine the worth of HUTCHMED DRC on a given historical date. On November 12, 2024 HUTCHMED was worth 17.51 at the beginning of the trading date compared to the closed value of 17.48. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of HUTCHMED DRC stock. Still, in general, we apply an absolute valuation method to find HUTCHMED DRC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of HUTCHMED DRC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against HUTCHMED DRC's related companies.
 Open High Low Close Volume
  17.72    17.87    17.40    17.64    86,606  
11/12/2024
  17.51    17.77    17.39    17.48    167,667  
  17.21    17.35    16.84    17.04    70,425  
Backtest HUTCHMED DRC  |  HUTCHMED DRC History  |  HUTCHMED DRC Valuation   PreviousNext  
Open Value
17.51
17.48
Closing Value
27.02
Upside

HUTCHMED DRC Trading Date Momentum on November 12, 2024

On November 13 2024 HUTCHMED DRC was traded for  17.04  at the closing time. Highest HUTCHMED DRC's price during the trading hours was 17.35  and the lowest price during the day was  16.84 . The net volume was 70.4 K. The overall trading history on the 13th of November 2024 contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 2.52% . The trading delta at closing time to current price is 0.29% .

HUTCHMED DRC Fundamentals Correlations and Trends

By evaluating HUTCHMED DRC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among HUTCHMED DRC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. HUTCHMED financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About HUTCHMED DRC Stock history

HUTCHMED DRC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HUTCHMED is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HUTCHMED DRC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HUTCHMED DRC stock prices may prove useful in developing a viable investing in HUTCHMED DRC
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2110 people.

HUTCHMED DRC Quarterly Net Working Capital

693.81 Million

HUTCHMED DRC Stock Technical Analysis

HUTCHMED DRC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of HUTCHMED DRC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of HUTCHMED DRC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

HUTCHMED DRC Period Price Range

Low
November 26, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

HUTCHMED DRC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

HUTCHMED DRC November 26, 2024 Market Strength

Market strength indicators help investors to evaluate how HUTCHMED DRC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HUTCHMED DRC shares will generate the highest return on investment. By undertsting and applying HUTCHMED DRC stock market strength indicators, traders can identify HUTCHMED DRC entry and exit signals to maximize returns

HUTCHMED DRC Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for HUTCHMED DRC's price direction in advance. Along with the technical and fundamental analysis of HUTCHMED Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of HUTCHMED to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether HUTCHMED DRC is a strong investment it is important to analyze HUTCHMED DRC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HUTCHMED DRC's future performance. For an informed investment choice regarding HUTCHMED Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(0.25)
Revenue Per Share
3.575
Quarterly Revenue Growth
(0.43)
Return On Assets
(0.06)
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.